Why do connected medical devices require stronger risk assessment than ordinary IT systems?

Because a weakness in a connected medical device can affect care delivery, not just data confidentiality. Risk assessment must consider exploitability, clinical impact, and the likelihood that a compromise could interfere with essential device performance. That is a different threshold from standard enterprise patching, where the primary concern is usually business disruption rather than patient harm.

Why This Matters for Security Teams

Connected medical devices sit outside the normal enterprise risk model because their compromise can change clinical outcomes, not just business operations. A missed patch or weak credential may expose protected data, but in a device environment the same weakness can interfere with therapy delivery, alarm integrity, telemetry, or availability at the point of care. That is why current guidance aligns more closely with safety engineering and resilience planning than with ordinary workstation hardening, as reflected in the NIST Cybersecurity Framework 2.0.

Risk decisions also need to account for how devices are deployed, who maintains them, and whether compensating controls can realistically be applied without disrupting treatment workflows. NHI Management Group’s Ultimate Guide to NHIs — Why NHI Security Matters Now notes that 90% of IT leaders say properly managing NHIs is essential for Zero Trust, which is especially relevant when service accounts, remote support tools, and machine-to-machine credentials are tied to clinical environments.

In practice, many security teams encounter device risk only after a maintenance outage, unsafe downgrade, or credential exposure has already affected care delivery.

How It Works in Practice

Effective assessment starts by separating device function from generic IT asset scoring. For connected medical devices, the most important questions are whether compromise can alter dosage, disrupt monitoring, delay alarms, or block clinicians from trusted data. That means risk evaluation must combine exploitability with patient safety impact, operational criticality, compensating controls, and the limits of vendor patch windows. The Ultimate Guide to NHIs — Key Challenges and Risks is useful here because device ecosystems often depend on secrets, service accounts, and third-party connectivity that are harder to inventory than ordinary endpoints.

A practical assessment usually includes:

• Classifying devices by clinical role, not just by operating system or asset owner.
• Mapping each device to the network paths, APIs, and support channels it uses.
• Reviewing whether credentials are unique, rotated, and scoped to the minimum task.
• Testing what happens when a device is offline, patched late, or forced into fallback mode.
• Evaluating whether monitoring can detect abnormal commands, configuration drift, or unusual authentication behavior.

This is where identity discipline matters. The NHIMG research on Top 10 NHI Issues highlights the operational reality that excessive privilege, stale secrets, and limited visibility are common failure modes across machine identities, and those weaknesses become more serious when the asset is a clinical device rather than a standard server. Risk teams should therefore treat remote access, update channels, and vendor support accounts as part of the device threat surface, not as separate administrative details. These controls tend to break down in multi-vendor hospital environments because legacy devices often cannot support modern logging, short-lived credentials, or rapid patching without affecting clinical uptime.

Common Variations and Edge Cases

Tighter device controls often increase operational overhead, requiring organisations to balance stronger protection against clinical continuity and vendor support constraints. That tradeoff is most visible when devices are old, safety-certified, or tied to proprietary management software that cannot easily accept standard enterprise controls. In those cases, best practice is evolving rather than settled, and risk assessment should explicitly document where technical hardening is impossible and compensating controls must carry the burden.

One common edge case is remote servicing. A vendor may need persistent access for troubleshooting, but long-lived access increases the chance that a compromised account becomes a pathway into treatment systems. Another is segmented networks that are secure on paper but still allow broad trust through update servers, shared credentials, or flat administrative domains. Connected medical devices also differ from ordinary IT systems because downtime is not always an acceptable remediation path; a blocked infusion pump or monitor can be clinically unacceptable even when security risk is well understood.

Security teams should therefore rate these environments by both cyber impact and patient harm, then revisit those ratings whenever a device changes firmware, connectivity, or support model.

Related resources from NHI Mgmt Group

• When do service accounts become a higher risk than ordinary user accounts?
• Why do CJIS environments require stronger auditing than ordinary enterprise systems?
• Why do connected medical devices increase hospital cyber risk?
• Why do connected medical devices create identity security risk for hospitals?